Metastatic breast cancer: The Odyssey of personalization
Metastatic breast cancer is the most frequent cause of cancer death for women worldwide. In the last 15 years, a large number of new agents have entered clinical use, a result of the dramatic increase in our understanding of the molecular underpinnings of metastatic breast cancer. However, while the...
Main Authors: | A. Sonnenblick, N. Pondé, M. Piccart |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-10-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1016/j.molonc.2016.07.002 |
Similar Items
-
The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling
by: Benjamin Verret, et al.
Published: (2022-08-01) -
Emerging intrinsic therapeutic targets for metastatic breast cancer
by: Li, Jiawei, et al.
Published: (2023) -
Role of Molecular Targeted Therapeutic Drugs in Treatment of Breast Cancer: A Review Article
by: Himanshu Singh
Published: (2023-06-01) -
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
by: Md Abdus Subhan, et al.
Published: (2023-04-01) -
Impact of Physical Rehabilitation on Bone Biomarkers in Non-Metastatic Breast Cancer Women: A Systematic Review and Meta-Analysis
by: Alessandro de Sire, et al.
Published: (2023-01-01)